18 Apr 2013, BioSpectrum Bureau , BioSpectrum
Singapore: Oramed Pharmaceuticals appointed Mr Joshua Hexter as chief operating officer and vice president of business development. Mr Hexter received his BA from the University of Wisconsin, US, and his Masters in Business Management from Boston University, US.
Most recently he was executive director of corporate in-licensing at BioLineRx. Mr Hexter brings to Oramed more than 15 years of prominent leadership with a commitment to excellence in the biotech industry in business development and operations.
Mr Nadav Kidron, CEO, Oramed, said that, "Josh will be a great addition and complement to Oramed's executive team as we enter a new era in our clinical trials and activities."